Treatment and blood pressure control in Spain during 2002-2010

Journal of Hypertension

Volumn 30, Issue 12, 2012, Pages 2425-2431

  Llisterri, Jose L ^a   Rodriguez Roca, Gustavo C ^b   Escobar, Carlos ^c   Alonso Moreno, F Javier ^d   Prieto, Miguel A ^e   Barrios, Vivencio ^f   González Alsina, Diego ^g   Divisón, Juan A ^h   Pallarés, Vicente ⁱ   Beato, Pere ^j  

^a Primary Care Center Ingeniero Joaquin Benlloch   (Spain)

^b Primary Care Center la Puebla de Montalban   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^d Primary Care Center Silleria   (Spain)

^e Vallobin La Florida Primary Care Health Center   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g Almirall Prodesfarma Pharmaceuticals ^*  (Spain)

^h Casas Ibáñez Primary Care Center   (Spain)

ⁱ Unió N de Mutuas   (Spain)

^j Primary Care Center Premià   (Spain)

more..

Author keywords

blood pressure control; evolution; primary care centers; Spain

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; MULTICENTER STUDY (TOPIC); OBESITY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEDENTARY LIFESTYLE; SPAIN;

EID: 84870255922     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283592583     Document Type: Review

References (33)

1. Lawes CM, Vander Hoorn S, Rodgers A, International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371:1513-1518.
2. de la Sierra A, Gorostidi M, Mar?́n R, Redón J, Banegas JR, Armario P, et al. Evaluation and management of hypertension in Spain. A consensus guide. Med Clin (Barc) 2008; 131:104-116.
3. Banegas JR, Rodr?́guez Artalejo F, Cruz JJ, Guallar P, Rey J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension 1998; 32:998-1002.
4. Banegas JR, Rodŕguez-Artalejo F, Ruilope LM, Graciani A, Luque M, Cruz JJ, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertens 2002; 20:2157-2164.
5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
6. Pardell H, Tresserras R, Armario P, Hernández del Rey R. Pharmacoeconomic considerations in the management of hypertension. Drugs 2000; 59 (Suppl 2):13-20.
7. Staessen JA, Gasowski J, Wang JG, Thijs L, Hond ED, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355:865-872.
8. Blood Pressure Lowering Treatment Trialists' Collaboration. Effect of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000; 355:1955-1964.
9. Lobos JM, Royo-Bordonada MA, Brotons C, Alvarez-Sala L, Armario P, Maiques A, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish adaptation. Rev Clin Esp 2009; 209:279-302.
10. Banegas JR, Jovell A, Abarca B, Aguilar Diosdado M, Aguilera L, Aranda P, et al. Hypertension and health policy in Spain. Med Clin (Barc) 2009; 132:222-229.
11. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
12. Mancia G, De Backer G, Dominiczack A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
13. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27:2121-2158.
14. Llisterri Caro JL, Rodr?́guez Roca GC, Alonso Moreno FJ, Lou Arnal S, Divisón Garrote JA, Santos Rodr?́guez JA, et al. Blood pressure control in Spanish hypertensive patients in Primary Healthcare Centers. PRESCAP 2002 Study. Med Clin (Barc) 2004; 122:165-171.
15. Llisterri Caro JL, Rodr?́guez Roca GC, Alonso Moreno FJ, Banegas Banegas JR, González-Segura Alsina D, Lou Arnal S, et al. Control of blood pressure in Spanish hypertensive population attended in primary health-care. PRESCAP 2006 Study. Med Clin (Barc) 2008; 130:681-687.
16. Llisterri Caro JL, Rodŕguez Roca GC, Alonso Moreno FJ, Prieto D?́az MA, Banegas Banegas JR, Gonzalez-Segura Alsina D, et al. Blood pressure control in hypertensive Spanish population attended in Primary Care setting. The PRESCAP 2010 study. Med Clin (Barc). 2012 Mar 19 [Epub ahead of print].
17. National Institute of Statistics. Life expectancy in Spain. INebase. http://www.ine.es. [Accessed May 2012].
18. Barrios V, Banegas JR, Ruilope LM, Rodicio JL. Evolution of blood pressure control in Spain. J Hypertens 2007; 25:1975-1977.
19. Coca A. Evolution of arterial hypertension control in primary care setting in Spain. Results from the Controlpres 2003 study [in Spanish]. Hipertension 2005; 22:5-14.
20. Egan BM, Zhao Y, Axon RN. US Trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303:2043-2050.
21. Fasce E, Campos I, Ibáñez P, Flores M, Zárate H, Román O, Fasce F. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens 2007; 25:1807-1811.
22. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011; 183:1007-1013.
23. Ćfková R, Skodová Z, Bruthans J, Holub J, Adámková V, Joz?́fová M, et al. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008. J Hypertens 2010; 28:2196-2203.
24. Kastarinen M, Antikainen R, Peltonen M, Laatikainen T, Barengo NC, Jula A, et al. Prevalence, awareness and treatment of hypertension in Finland during 1982-2007. J Hypertens 2009; 27:1552-1559.
25. Gonzalez JR, Alegria E, Aznar J, Bertomeu V, Franch J, Palma JL. Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and specialists. Rev Esp Cardiol 2006; 59:801-806.
26. Garcia-Pavia P, Gonzalez J, Pastorin R, Bruna M, Raez J, Tabuenca AI, et al. Epidemiological analysis of the improving areas for blood pressure control at primary care practice. Rev Clin Esp 2006; 206:220-224.
27. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
28. Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, van der Velde G, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA 2010; 303:1841-1847.
29. Barrios V, Escobar C, Murga N, de Pablo C, Bertomeu V, Calderón A, et al. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice. J Hypertens 2008; 26:2230-2235.
30. Coca A, Aranda P, Bertomeu V, Bonet A, Esmatjes E, Guillen F, et al. Strategies for effective control of arterial hypertension in Spain. Consensus document. Rev Clin Esp 2006; 206:510-514.
31. Barrios V, Escobar C, Calderón A, Llisterri JL, Echarri R, Alegr?́a E, et al. Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in Spain. J Clin Hypertens (Greenwich) 2007; 9:324-329.
32. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al., HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358:1887-1898.
33. Barrios V, Coca A, Escobar C, Enrique R, Rincón LM. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice. Expert Rev Cardiovasc Ther 2012; 10:159-166.